期刊文献+

硫辛酸联合甲钴胺治疗糖尿病周围神经病变的疗效观察 被引量:2

下载PDF
导出
摘要 糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)是糖尿病常见的慢性并发症之一,临床症状多以感觉过敏及感觉减退为主要表现,常常给患者带来极大痛苦。本研究分别将硫辛酸。
出处 《中国药物与临床》 CAS 2011年第12期1452-1453,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献4

二级参考文献48

  • 1贾伟平,沈琴,包玉倩,陆俊茜,李鸣,项坤三.糖尿病周围神经病变的检测方法及其诊断价值的评估[J].中华医学杂志,2006,86(38):2707-2710. 被引量:86
  • 2Spruce MC, Potter J, Coppini DV. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med, 2003,20 : 88-98.
  • 3Biessels GJ, ter Laak MP, Hamers FP, et al. Neuronal Ca2+ disregulation in diabetes mellitus. Eur J Pharmacol, 2002,447:201-209.
  • 4Muck W, Heine PR,Breuel HP, et al. The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus. Int J Clin Pharmacol Ther,1995,SS:89-94.
  • 5Castagno PL, Di Molfetta L, Merlo M, et al. Prospects of prostanoid therapy. Preliminary results. Minerva Cardioangiol,2000,48:9-18.
  • 6Koriyama T, Inafuku S, Kimata K, et al. Recent-onset bell palsy complicated by diabetes: comparison of steroid and lipoprostaglandin E(1) therapy. Arch Otolaryngol Head NeckSurg, 2001,127 : 1338-1340.
  • 7Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg, 1992,94:105-111.
  • 8Emanuelia C, Madeddu P. Human tissue kallikrein:a new bullet for the treatment of ischemia. Curr Pharm Des, 2003, 9:589-597.
  • 9Emanueli C, Madeddu P. Angiogenesis therapy with human tissue kallikrein for the treatment of isehemie diseases. Arch Mal Coeur Vaiss,2004,97:679-687.
  • 10Adler AI, Boyko EJ, Ahroni JH, et al. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care, 1999,22 : 1029-1035.

共引文献48

同被引文献15

  • 1梁昱.抗肿瘤化疗药物所致的神经毒性研究进展[J].临床内科杂志,2006,23(6):430-432. 被引量:27
  • 2黄静,刘波,刘凤月.甲钴胺治疗糖尿病周围神经病变与维生素B_(12)B_1联用疗效比较[J].山西医药杂志,2006,35(11):1034-1035. 被引量:13
  • 3韩晓光,陈永祥.银杏达莫联合甲钴胺治疗糖尿病周围神经病变的临床观察[J].山西医药杂志,2007,36(11):1042-1044. 被引量:5
  • 4Von Delius S, Eckel F, Wagenpfeil S. Cabmnazepine for prevention of oxaliplatin-relaed neurotoxicity in patients with advanced colorectal cancer: final results of a randomised controlled, muhicenter phaseII study[J]. Invest New Drugs, 2007, 25(2) : 173-180.
  • 5RaoRD , Michalak JC , Sloan JA , et al. Eficacy of gabapentin in the managementchemotherapy-induced peripheralneuropathya phase 3 randomized, double-blind, placebo-controlled, crossover trial [ J ]. Cancer,2007, 110(9) : 2110-2118.
  • 6Effects of ramipril on cadiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Preventio Evaluation Study Investigators[J]. Lance,2000, 355 (9200) : 253-259.
  • 7Ziegler D, Reljanovic M, Mehnert H, et al. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in germany: current evidence from clinical, trials. [ J ]. Exp Clin E ndocr Diabetes, 1999,107 ( 7 ) : 421-30.
  • 8Stevens MJ, Obrosova I, Cao X, et al. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabeticneuropathy [ J]. Diabetes, 2000,49(6) :1006-1115.
  • 9Kuwabara S, Nakazawa R, Azuma N,et al. Intravenous methyl-cobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients [ J ]. Internal Medicine, 1999,38 (6) :472-475.
  • 10田峰,杨小红,张大敏,吴莹.α硫辛酸治疗糖尿病周围神经病变42例临床观察[J].实用医学杂志,2008,24(12):2158-2159. 被引量:16

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部